Information About Vaxzevria

Disclaimer: The information on this page is intended for Vaccine Recipients only.

Vaxzevria has been given ‘conditional approval’. This means that there is more evidence to come about this medicine. The European Medicines Agency will review new information on this medicine at least every year and the leaflet will be updated as necessary.

You can find more information here (https://www.ema.europa.eu/en).

Please refer to your Healthcare Provider for further information, or you can contact the AstraZeneca Medical Information team here. 

During the pandemic, Vaxzevria may also be distributed in packaging with the name COVID‑19 Vaccine AstraZeneca.

Patient Information Leaflet (PIL) [English]
Patient Information Leaflet (PIL) [Malti]
Blue Box
Traceability and Vaccination Reminder Card

Report an Adverse Event via the Medicines Authority ADR website

If you are concerned about an adverse event, it can be reported via the Medicines Authority ADR website:  www.medicinesauthority.gov.mt/adrportal

Report an Adverse Event via Medicines Authority ADR website

This link will take you to another website. AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

© AstraZeneca. All rights reserved.

This website is intended for people seeking information on Vaxzevria

exit ramp cf

azcovid-cf-text

You are now leaving azcovid-19.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s Vaccine site or ‘continue’ to proceed.

az-cancle-cta
Cancel
az-submit-cta
Continue